Delivery Order 75N91024D00009-75N91024F00002
Award Date
9/13/24
Potential Completion Date
9/12/29
Potential Value
$2.4M
Federal Agency
National Cancer Institute
Awardee
Arbor Research, LLC
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Ann Arbor, MI 48108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $84,241.00 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Arbor Research, LLC, a for-profit limited liability company, for the Global Cancer Research and Control Seminar Series (GCRCSS). The contract has a period of performance through September 2025 and is not set aside for any specific business type. Arbor Research, which does business as Urrea, is a subcontractor to Synergy Enterprises, Inc., a minority-owned, woman-owned small business,...
This federal contract award was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services (HHS). The contract, valued at $16,500, is for laboratory testing services and has an ultimate completion date of September 30, 2010. The prime contractor for this award is Arbor Research Collaborative for Health, doing business as Urrea, a non-profit organization that specializes in health-related research, program evaluation, and quality...
This is a delivery order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the Institute for Defense Analyses (IDA), a non-profit research organization. The contract, valued at $329,514.57, is for "OTHER FUNCTIONS NCI COMMUNITY ONCOLOGY RESEARCH PROGRAM (NCORP)". It is not a set-aside contract. IDA, the prime contractor, may engage subcontractors like Aeris, Noblis, and Lightcast to contribute specialized capabilities....
This is a federal contract award to Arbor Research Collaborative for Health, a non-profit organization, by the Centers for Medicare and Medicaid Services (CMS). The $20,907,838.00 cost-plus-fixed-fee contract is for critical functions under CMS's Research Measurement Assessment Design and Analysis (RMADA) indefinite delivery, indefinite quantity (IDIQ) contract. The contract has a period of performance through September 26, 2023. Arbor Research Collaborative for Health, which also does...
This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
This is a $29,760,269.00 definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. government, to the National Opinion Research Center (NORC), a non-profit research organization. The contract is for support services to establish and study a prospective U.S. cohort within healthcare systems to research cancer. This contract is not set aside for small businesses. NORC, the prime contractor, has a history of providing comprehensive survey research, data...
This is a delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services, to The Institute for Cancer Research, a non-profit research organization and subsidiary of Temple University. The $988,252 firm fixed price contract is for research and development services in the area of biomedical basic research, specifically preclinical efficacy and biomarker analysis to support the NCI's PREVENT Cancer Preclinical Drug Development Program....
This is a federal contract award from the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $7,053,827.00, was awarded to the University of Maryland, Baltimore (UMB) to serve as a resource for the collection of human tissue, cells, biofluids, and epidemiologic profiles from donors to support NCI's Laboratory of Human Carcinogenesis research programs. The contract has a 1-year base period and four 1-year option...
This federal contract award was made by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The award, valued at $1,076,616.60, is for Scientific Support Services for a Medical Officer 9 to support the Office of Sponsor and Regulatory Oversight within the NCI's Center for Cancer Research. The contract is a Blanket Purchase Agreement (BPA) Call issued under the Multiple Award Schedule (MAS) contract vehicle,...
This is a $580,503.00 delivery order award under the Cancer Prevention Agent Development Program 2012-2017 indefinite delivery contract issued by the National Cancer Institute, a component of the U.S. Department of Health and Human Services. The order was awarded to the University of Arizona, doing business as the Arizona Board of Regents, for research and development services to support core infrastructure for the agency's cancer prevention agent development efforts. The work will be...